Literature DB >> 1885580

Mutational analysis of the ligand-binding domain of the prolactin receptor.

M Rozakis-Adcock1, P A Kelly.   

Abstract

The recent isolation and sequencing of the rat liver prolactin (PRL) receptor cDNA (clone F3) revealed that the receptor is a small molecular weight protein (nonglycosylated form, Mr 33,000; glycosylated form, Mr 42,000) comprised of 291 amino acids. A second form of the PRL receptor exists (591 amino acids) that contains a much longer cytoplasmic domain. In the present study, site-directed point mutations of the 5 conserved cysteine (Cys) residues and of the three potential N-linked glycosylation sites in the extracellular domain of the rat PRL receptor were constructed to assess their involvement in hormone binding. In addition, a truncation mutant (T delta 237) lacking 55 of 57 intracellular amino acids was constructed to determine the influence of the cytoplasmic domain on ligand-receptor interactions. Binding studies of transiently transfected COS-7 cells demonstrated that serine substitution of the first 4 Cys residues (Cys12, Cys22, Cys51, and Cys62) completely eliminated binding of 125I-ovine PRL and 125I-U5 and -U6, two monoclonal antibodies that bind the receptor molecule outside the PRL-binding domain. RNA blot analysis of the transfected cells showed that both the wild-type and mutant clones had similar levels of expression of receptor mRNA. Immunoblot analysis demonstrated that lack of PRL binding in these mutants was not due to incomplete processing of the protein, since the fully glycosylated Mr 42,000 form of the receptor was seen. Mutation of Cys184 had no effect on affinity or dimerization capacity of the receptor, suggesting the 5th cysteine is not directly involved in the binding domain. Carbohydrate groups of some receptors have been shown to be involved in ligand-receptor interactions as well as intracellular trafficking. This does not appear to be the case for the PRL receptor, since there was no corresponding decrease in affinity for PRL or cell surface receptor expression, following mutation of each of the 3 asparagine residues to aspartate. Interestingly, T delta 237 showed a 4-5-fold increase in affinity for PRL as well as a marked increase in the number of receptor sites. Whole cell binding assays also demonstrated that loss of the cytoplasmic domain lead to inefficient recycling of the receptor. These studies suggest that the first 4 conserved Cys residues are crucial for ligand binding.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Mammary gland development in prolactin receptor knockout mice.

Authors:  C J Ormandy; N Binart; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein.

Authors:  L I Zon; J F Moreau; J W Koo; B Mathey-Prevot; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

3.  Expression cloning of a cDNA encoding a fish prolactin receptor.

Authors:  O Sandra; F Sohm; A de Luze; P Prunet; M Edery; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

4.  Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2.

Authors:  Isabelle Broutin; Jean-Baptiste Jomain; Estelle Tallet; Jan van Agthoven; Bertrand Raynal; Sylviane Hoos; Birthe B Kragelund; Paul A Kelly; Arnaud Ducruix; Patrick England; Vincent Goffin
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

5.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

Authors:  S S Watowich; D J Hilton; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.

Authors:  Y-L Xie; S A Hassan; A M Qazi; C H Tsai-Morris; M L Dufau
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

7.  Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization.

Authors:  D E Quelle; F W Quelle; D M Wojchowski
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor.

Authors:  D J Hilton; S S Watowich; P J Murray; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

9.  Homodimerization and constitutive activation of the erythropoietin receptor.

Authors:  S S Watowich; A Yoshimura; G D Longmore; D J Hilton; Y Yoshimura; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 10.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.